SARS-CoV-2 Omicron

Young-Jun Park1,2, Dora Pinto3, Alexandra C Walls1,2

  • 1Department of Biochemistry, University of Washington, Seattle, WA, USA.

Science (New York, N.Y.)
|October 20, 2022
PubMed
概括

混合免疫和疫苗增强剂产生对SARS-CoV-2 Omicron亚系的中和抗体. 突破性感染与单独接种疫苗不同,诱导鼻免疫,大多数抗体与各种Omicron变体发生交叉反应.